Douglas Lane & Associates, LLC Sanofi Transaction History

Douglas Lane & Associates, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 09, 2018	SELL	$40.0 - $44.84 $336,200 - $376,880	-8,405 Closed	0 $0
Q2 2018 Jul 23, 2018	SELL	$37.63 - $41.22 $406,817 - $445,629	-10,811 Reduced 56.26%	8,405 $336,000
Q1 2018 Apr 23, 2018	SELL	$38.98 - $45.76 $483,001 - $567,012	-12,391 Reduced 39.2%	19,216 $770,000
Q4 2017 Jan 24, 2018	SELL	$42.86 - $50.61 $742,120 - $876,312	-17,315 Reduced 35.39%	31,607 $1.36 Million
Q3 2017 Oct 19, 2017	BUY	$47.04 - $50.34 $2.3 Million - $2.46 Million	48,922	48,922 $2.44 Million

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $123B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Douglas Lane & Associates, LLC with notifications on news.